ArticleScience advances2023

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.

Kai Rejeski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.